2019
DOI: 10.1016/j.eujim.2018.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Effects of dietary and lifestyle recommendations on patients with glaucoma: A randomized controlled pilot trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…The few clinical investigations that have been conducted on individuals with POAG have examined any potential ocular hypotensive effects, and their findings have been conflicting. Saffron supplementation (1 g twice a week) in a randomized controlled pilot study did not seem to have an impact on IOP in the near term (1 month) [67]. However, according to a different pilot study carried out on 34 clinically stable POAG patients, oral saffron supplementation (30 mg daily for one month) can considerably lower IOP after three weeks.…”
Section: Crocus Sativus L (Saffron)mentioning
confidence: 94%
“…The few clinical investigations that have been conducted on individuals with POAG have examined any potential ocular hypotensive effects, and their findings have been conflicting. Saffron supplementation (1 g twice a week) in a randomized controlled pilot study did not seem to have an impact on IOP in the near term (1 month) [67]. However, according to a different pilot study carried out on 34 clinically stable POAG patients, oral saffron supplementation (30 mg daily for one month) can considerably lower IOP after three weeks.…”
Section: Crocus Sativus L (Saffron)mentioning
confidence: 94%
“…Conversely, a single clinical study reported a decrease of only 1 mmHg in the intraocular pressure of normotensive subjects after the oral supplementation with omega-3 [ 235 ]. Additionally, the dietary supplementation of natural extracts based on Ginkgo biloba, green tea catechins, saffron, and black currant anthocyanins demonstrated antioxidant and neuroprotective properties in animal models [ 236 , 237 , 238 ] but no clinical efficacy to treat glaucoma [ 239 , 240 , 241 , 242 , 243 ].…”
Section: Treatmentmentioning
confidence: 99%
“…In glaucoma, there are two studies in patients on the possible hypotensive effect of saffron that show contradictory results. In patients with primary open-angle glaucoma, using a dose of 1g twice a week, no hypotensive effect was observed [101]. However, in another study using a dose of 30 mg per day, a decrease in intraocular pressure (IOP) was found [102].…”
Section: Saffronmentioning
confidence: 99%